S turge-Weber syndrome (SWS) is a congenital capillaryvenous vascular malformation involving the brain (leptomeningeal angioma), skin (capillary malformation), and eye. 1 The neurological manifestations of SWS frequently evolve over the lifetime of the individual. Although this process has been best studied in infants and young children with SWS, it is clear that patients can also present with new neurological symptoms in adulthood and more research is also needed in this area. In the last decade, advanced neuroimaging and several clinical cohort studies of patients with SWS have brought into focus a greater understanding of the range of clinical manifestations, improved our understanding of neurological deterioration, and suggested promising new avenues for early diagnosis and treatment.
NEUROLOGICAL SIGNS AND SYMPTOMS IN SWS
Most commonly, patients with brain involvement will present with a seizure in infancy. Typically, seizures are focal motor seizures, which can be very subtle in infants; complex partial seizures are also common. A small but significant subgroup will also have atonic seizures, and carbamazepine or oxcarbazepine can make these worse. 2, 3 Infantile spasms are rare but have been reported and are usually asymmetric. 4 Status epilepticus is not uncommon and is frequently associated, with prolonged weakness on 1 side of the body or new onset visual field deficit (lasting several days, weeks, or months), referred to as a stroke-like episode. 5 Clusters of seizures, separated by many months or years of seizure freedom, are also common. 3 In most cases, epilepsy begins in infancy or young childhood; however, seizures can occasionally begin in adulthood and be the presenting symptom in an otherwise neurologically intact individual. 6 Seizures occur in roughly 75% of SWS patients with unilateral brain involvement and in approximately 95% of patients with bilateral brain involvement. 7, 8 Rarely, instead of presenting with acute seizures, infants with SWS brain involvement present with early handedness, evidence of hemiparesis, or a visual gaze preference.
Neurological deficits can be acquired slowly over time, or as the result of stroke-like episodes associated with seizures and/or migraines. 1 Toddlers and young children are particularly prone to stroke-like episodes triggered by falls with minor head injury. 9 On account of this propensity, patients with SWS should be advised to avoid recreational activities that are expected to frequently involve blows to the head. Seizure onset at <6 months of age has been related to increased severity of hemiparesis in a cohort of 77 patients seen at 1 center. 3 Most adults with SWS brain involvement have some degree of focal neurological deficit, usually hemparesis. 10 Neurological deterioration is more common in infants and young children, but strokes and acquisition of new neurological deficits can also occur in adults. Early onset dementia in the fifth or sixth decade can also occur but is poorly understood (clinical observation).
Cognitive impairments are common in patients with SWS but range greatly from attention problems or mild learning disability to severe cognitive impairment. Early onset of hard to control seizures and bilateral brain involvement may predict for more severe cognitive impairments. 11 Neuropsychological testing starting at the age of 3 or 4 years can be helpful in identifying at-risk children. A recent study indicated that children with SWS and hemiparesis are likely to have global functional impairments, suggesting that hemiparesis on neurological examination marks the young child who will likely benefit from neuropsychological testing even in the absence of obvious delays. 12 Attention problems are responsive to stimulants (unpublished observations) which should be considered where suitable. Aggression and self-abusive behaviors are frequent in intellectually impaired adults with SWS. Depression is common in adults with SWS, particularly in those who are intellectually normal. 10 Headaches and migraines are common in SWS and, in adults, can more severely impact their quality of life than do their seizures. 13 In patients with SWS, migraines frequently precede seizures; likewise seizures are frequently followed by headaches. Both seizures and migraines can be accompanied by a stroke-like episode. A recent report of an adult with SWS during an episode of intractable headache with prolonged visual aura highlighted focal hyperemia on single-photon emission computed tomography (SPECT), increased extent of occipital sulcal enhancement on magnetic resonance imaging (MRI) with contrast, and occipital retention of contrast on computed tomography angiography during the headache. These findings resolved completely after the event and suggested a component of venous stasis. 14 Miller et al 15 reported an increased prevalence of growth hormone deficiency in SWS (18-fold greater than the general population). Neuroimaging did not show apparent abnormalities involving the hypothalamic-pituitary axis and the cause of this deficiency remains uncertain. Nevertheless, growth hormone deficiency is a treatable cause of short stature or growth failure in patients with SWS. Very short adults with SWS should be evaluated for growth hormone deficiency, as this condition left untreated in adults can result in depression and medical problems.
Furthermore, central hypothyroidism associated with SWS has also been reported. 16 The etiology of the central hypothyroidism is also not entirely clear. All children with SWS who have been diagnosed by us with central hypothyroidism (persistently low free T4 and low normal thyroidstimulating hormone) have been on chronic anticonvulsants. Central hypothyroidism (both symptomatic and asymptomatic) has been associated with the use of several of the anticonvulsants. [17] [18] [19] However, given the increased risk of growth hormone deficiency in SWS, disruption of the hypothalamicpituitary axis could also be a contributor to the central hypothyroidism issue.
Diagnosis of SWS Brain Involvement
SWS brain involvement should be suspected in any newborn with a port-wine birthmark (PWB, aka port-wine stain) in the V1 distribution (forehead to 1 side and/or upper eyelid). A PWB of any size in that location has approximately a 10% to 20% risk of SWS brain involvement. However, the risk increases with the size, extent, and bilaterality of the birthmark. 20, 21 Approximately 10% of those with typical SWS brain involvement will have no birthmark or eye involvement. These patients usually present with focal seizures later in childhood or adulthood and generally respond well to medical management. Unless the MRI is done with contrast, however, this diagnosis will be missed. 22 SWS brain involvement is diagnosed by visualization of the typical leptomeningeal vascular malformation on contrast enhanced T1-weighted MRI imaging ( Fig. 1) . Associated dilation and enhancement of the choroid plexus (glomus) on the involved side is also often present in older children and adults, dilated deep draining venous vessels underlying the effected cortical region may also be seen. Cortical and subcortical calcification is best seen on head CT (Fig. 2) .
Early presymptomatic diagnosis of SWS brain involvement, however, is difficult because standard MRI and CT 
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imaging have low sensitivity in the newborn period and early infancy. A negative head CT and/or contrast enhanced MRI of the brain in a normally developing asymptomatic young infant with a facial PWB does not exclude SWS brain involvement. The optimal timing of the first neuroimaging is unknown but current clinical experience suggests that if the child is developing normally, has a normal neurological examination, no history of seizures, and a normal MRI with contrast after the age of 1 year, that child probably does not have SWS brain involvement. Postcontrast flair and susceptibility-weighted MRI may provide additional sensitivity for involved brain areas. 23, 24 Quantitative electroencephalography (qEEG) is a promising new screening strategy currently being developed to select the most appropriate at-risk infants for neuroimaging. A decrease in qEEG power on the affected side correlates with the severity of neurological deficits. 25 Ewen et al 26 recently described a qEEG approach that separated a group of 9 infants with facial PWB into affected and unaffected groups. If successfully applied to larger numbers of infants and EEGs from other facilities, this approach may prove to be a very useful tool for screening at-risk infants to determine who should receive an early MRI with contrast and which parents can be reassured and wait for later imaging.
INSIGHTS FROM FUNCTIONAL IMAGING
The vascular malformation of the brain consists of hypoplastic cortical vessels associated with enlarged, tortuous leptomeningeal vessels and, frequently, with dilated deep venous vessels. Perfusion imaging suggests that impaired venous drainage from the involved brain regions results in impaired arterial perfusion. 27 Eleven SPECT studies in young infants with SWS demonstrated that cerebral perfusion declines from being generous in the very young infant to being deficient in the involved cortical regions by the end of the first year of life. 28 One reason that MRI with contrast is insensitive in newborns may be that the venous stasis and impaired blood flow dynamics have not yet developed. Two studies have reported ictal SPECT in a total of 4 individuals with SWS and showed that, during seizures, reduced increases in blood flow to the seizing hemisphere develop, or an absolute reduction in blood flow to ischemic levels occur in the involved or remote brain areas. 29, 30 This finding suggests an abnormal vascular response to the seizures in SWS which likely further predisposes these patients to ischemic brain injury.
The question of whether seizures themselves exacerbate brain injury in SWS or are just a manifestation of the ischemiainduced brain injury remains controversial. When an infant or young child with SWS seizes for a prolonged period (status), they commonly have new or greatly worsened hemiparesis, new visual field cut, and may regress in language and other cognitive milestones as well. This is often more than a Todd paralysis, as it may not fully resolve within a day, though it can improve or resolve over weeks and months if the child is subsequently free of seizures and stroke-like episodes. Given the ictal SPECT finding described above, abnormal autoregulation of blood flow during a long seizure or bout of multiple seizures is likely 1 mechanism for how seizures can exacerbate brain injury in SWS. This information argues for the aggressive management of seizures in SWS, especially early in the course of the disease.
Eventually, positron emission tomography (PET) imaging demonstrates decreased glucose metabolism in affected regions and can be useful in planning surgical resection by enhancing detection of abnormal brain regions. In most cases, seizures ensue, and when uncontrolled in young children, are associated with further deterioration in glucose metabolism over time in the affected brain regions. In contrast, if seizures are well controlled for a prolonged period of time, glucose metabolism on PET imaging may improve. 31 These PET imaging findings concur with the clinical observation that children whose seizures are well controlled generally make better developmental progress and their hemiparesis and visual field deficit will often improve as well.
PATHOGENESIS OF SWS AND NEUROLOGICAL PROGRESSION
A somatic mutation or double-hit mechanism for the etiology of SWS has been proposed, 32 as the vascular malformation in SWS is usually localized to 1 region on 1 side of the body. During first trimester fetal development, the primitive vascular plexus invades the developing brain, skin, and eye, and a somatic mutation could derail the normal vascular maturation process. An alternative hypothesis proposed by Dr Parsa 33 suggested that all the main features of SWS arise from a localized primary venous dysplasia in the brain, with venous hypertension transmitted to the overlying skin and eye by persisting communicating collateral venous vessels. This putative brain venous dysplasia could itself be caused by a somatic mutation, however, this hypothesis does not well explain individuals with extensive bilateral facial PWBs and no evidence of SWS brain involvement at several years of age (clinical observation). The SWS vascular anomalies could result also from an environmental insult; however, to date no maternal risk factor has been identified for the development of SWS. Nevertheless, in the effort to eventually create a plausible animal model of SWS, or to someday discover a strategy for preventing it altogether, both of these possible causative mechanisms need to be considered.
Microscopic examination of SWS brain tissue shows deposition of calcium in the cortex, hypoplastic blood vessels, gliosis, and sometimes loss of neurons or focal cortical dysgenesis. The meningeal vessels are enlarged and increased in number. Anoxic injury to endothelial cells or perithelial cells may contribute to the calcification. However, enhancement of the leptomeningeal vessels and enlarged deep venous vessels suggests breakdown of the blood-brain barrier, and calcification could therefore, also result from increased blood vessel permeability. 34 PWB blood vessels lack perivascular nerves, 35, 36 and SWS cortical vessels are innervated only by noradrenergic sympathetic nerve fibers. 37 Increased endothelin-1 expression was found in SWS vascular malformations. 38 Together these studies suggest that there may be increased vasoconstrictive tone in the SWS brain vascular malformation; however, it is not known whether these alterations are pathologic or compensatory. Leptomeningeal vessels in SWS overexpress fibronectin, 39 vascular endothelial growth factor, the vascular endothelial growth factor receptor, and hypoxia-inducible factor-1. 40 Increased endothelial proliferation and apoptosis are also reported. Therefore, the abnormal leptomeningeal blood vessels show evidence of ongoing vascular remodeling rather than being static lesions. However, this remodeling may provide a compensatory mechanism to maintain blood flow and therefore, at this time, it is unadvisable to try treatment of SWS brain involvement with anti-angiogenesis factors.
TREATMENT OF NEUROLOGICAL SYMPTOMS
As prolonged and frequent seizures seem to have a contributing role in the progression of neurological injury, particularly in infants and young children. Therefore, educating parents on how to recognize and promptly treat seizures in SWS is important. Typically, the seizures in infants are subtle with rhythmic and persistent twitching of the hand or foot or deviation or nystagmus of the eyes. If the parents are expecting seizures to manifest with generalized tonic-clonic activity, they may watch focal activity for hours without seeking medical attention. I provide rectal diazepam for infants older than 3 months of age; even before definite brain involvement has been diagnosed in at-risk infants (as seizures may present before diagnosis can firmly be established or excluded). Working with the parents and the local hospital, a plan should be made for the child to be loaded with phosphenytoin as soon as possible and a chronic anticonvulsant initiated after the first focal seizure, as additional seizures invariably follow. As bouts of seizures often occur during periods of illness, and venous stasis also has a role in strokes and stroke-like episodes, aggressive hydration, fever treatment, and appropriate treatment of any infections are also important. Similarly, patients and family members should, when able, receive the flu shot annually. It also make sense that iron deficiency and other causes of anemia, when present, should be diagnosed and treated.
As venous stasis and microvascular thrombosis probably contribute to neurological decline in SWS, daily antiplatelet, low-dose aspirin (3 to 5 mg/kg/d) has been used empirically in children with SWS. 41 One small, open-label study found a decrease in the number of stroke-like episodes in patients with SWS receiving low-dose aspirin. 5 Udani et al 42 reported on 6 patients with SWS where the initiation of low-dose aspirin was associated with a decrease in seizures. Low-dose aspirin can be started at the onset of seizures or other focal neurological deficits; alternatively some parents and physicians decide to start this as soon as presymptomatic brain involvement is established on imaging. Larger prospective open-label studies are currently underway. Other forms of anticoagulation have yet to be studied in SWS, and therefore no information is available on which to base recommendations.
Chronic anticonvulsant use is central to the neurological treatment of the majority of children and adults with SWS who have epilepsy. Oxcarbazepine is an obvious first-line medication; however, we recently described patients with SWS who were on oxcarbazepine and developed evidence of central hypothyroidism associated with symptoms that improved after treatment with levothyroxine. 16 As discussed previously, this issue may arise secondary to the use of some anticonvulsants and has been described in association with oxcarbazepine. One study in 18 girls with epilepsy treated with oxcarbazepine showed that 67% developed asymptomatic central hypothyroidism that resolved when their medication was changed. 18 Another report noted symptomatic central hypothyroidism in 3 patients with epilepsy that were treated either with levothyroxine (2 cases) or changing their anti-epilepsy drugs (AED). 17 However, this issue has subsequently raised a significant treatment dilemma. Persistent central hypothyroidism associated with symptoms such as constipation, excessive sleepiness, decline in attention and cognitive skills, excessive weight gain, and poor vertical growth has now been diagnosed in several children with SWS on oxcarbazepine (clinical observation). It is difficult to determine whether these symptoms are due to the central hypothyroidism, the natural history of the SWS itself, or some other side effect of their medications. Other AEDs that can be considered as alternative or first-line AEDs are levetiracetam and topiramate. When the child's seizures are well controlled, however, the parents are frequently reluctant to switch them to another AED. A trial of levothyroxine may then be tried to determine whether symptoms improve and hypothyroidism resolves.
The older child with SWS tends to stabilize 1, 31 and if doing reasonably well can be expected to continue to do so. However, adolescence can be another time of instability with regards to seizure control, with seizures sometimes restarting in individuals who have been seizure-free for years. If the seizures in an older child or adult are extremely prolonged (several hours) or associated with severe illness, a stroke with new permanent deficits can still result, however, this is uncommon. Nevertheless, the adolescent and young adult should be strongly cautioned against excessive and risky behaviors that would greatly increase their risk of severe seizures. Clinical experience and a recent survey 43 suggests that sleep deprivation is a common trigger for both migraines and seizures in this group and firm education regarding this fact can help bring seizures under control in some cases.
Despite several series demonstrating that surgical resection is effective, and although early hemispherectomy has been recommended, there is still debate about patient selection and the timing of surgery. [44] [45] [46] [47] Surgery should not be considered at the time of diagnosis, as the agreed upon indication is medically refractory seizures. Those patients who have daily or weekly seizures associated with hemiparesis, visual field deficits, and significant developmental delays despite adequate trials of at least a couple of anticonvulsants (and arguably also low-dose aspirin) are very reasonable surgical candidates. The most difficult patients to advise are those with infrequent, but significant, seizure clusters separated by many months of seizure freedom and good developmental gains, and those patients with no or only mild neurological deficits. Surgery should only be done at a center with a pediatric epilepsy surgery program; despite surgical improvements and growing experience, there is risk from intracranial hemorrhage and infection in patients with SWS. Long-term seizure freedom is clearly associated with complete resection of the involved brain regions, 46, 47 however, this approach may increase the risk of morbidity. Vision is a particularly important issue, as surgery frequently results in a visual field deficit and glaucoma may also threaten vision in the affected eye(s); therefore, overall risks to vision is a serious consideration. Hemispherectomy can be considered for children with bilateral brain involvement when monitoring establishes that most of the seizures are clearly coming from 1 hemisphere. 48 Vagal nerve stimulator has occasionally been used in this population but little data are available to guide its use; results we have seen are consistent with the experience in other epilepsy populations.
Headaches and migraines in SWS are treated with standard abortive medications and, when frequent or severe, with preventative medications. Personal triggers for migraines should be sought and behavior modified where possible. A survey of 74 patients with SWS and migraine reported that 35% used headache preventative medication. 43 Preventative medications effective in reducing both seizures and migraines, such as topiramate, valproate, and gabapentin, should be considered first. We also have experience with verapamil and periactin and have found them useful. The survey also reported that 22% of patients had received triptans and many experienced improvement; no strokes, hemorrhages, or other serious complications were reported. 43 Although use of triptans seems to be safe, the individual response to triptans should be carefully monitored. In many patients, headaches precede their stroke-like episode or seizure event and in these
